Paul Schimmel, Director at Alnylam Pharma, holds 1.00M shares in aTyr Pharma (Ticker: LIFE), holds 307.00K shares in Alnylam Pharma (Ticker: ALNY), holds ― shares in Forte Biosciences (Ticker: FBRX). Most recently, Paul Schimmel Bought ― shares of aTyr Pharma on May 11, 2023 for an estimated value of 450.00K.